These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8140962)

  • 1. Coronary artery disease in women: diagnosis and prevention.
    Oettgen P; Douglas PS
    Adv Intern Med; 1994; 39():467-84. PubMed ID: 8140962
    [No Abstract]   [Full Text] [Related]  

  • 2. Where women stand today in primary prevention of coronary heart disease.
    Drown DJ
    Prog Cardiovasc Nurs; 1997; 12(2):34-6. PubMed ID: 9195646
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary heart disease: a substantial threat to women.
    Wenger NK
    J Med Assoc Ga; 1997 Sep; 86(3):187-91. PubMed ID: 9293170
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronary artery disease prevention: what's different for women?
    Bedinghaus J; Leshan L; Diehr S
    Am Fam Physician; 2001 Apr; 63(7):1393-400, 1405-6. PubMed ID: 11310652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying women at risk for coronary artery disease.
    Birchfield PC
    AAOHN J; 2003 Jan; 51(1):15-22. PubMed ID: 12596341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE.
    Palmieri L; Donfrancesco C; Giampaoli S; Trojani M; Panico S; Vanuzzo D; Pilotto L; Cesana G; Ferrario M; Chiodini P; Sega R; Stamler J
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):562-70. PubMed ID: 16874146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician knowledge levels and barriers to coronary risk prevention in women: survey results from the Women and Heart Disease Physician Education Initiative.
    Barnhart J; Lewis V; Houghton JL; Charney P
    Womens Health Issues; 2007; 17(2):93-100. PubMed ID: 17403466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for coronary heart disease in women.
    Newton KM
    Nurs Clin North Am; 2004 Mar; 39(1):145-63. PubMed ID: 15062733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing coronary heart disease in women.
    Rollini F; Mfeukeu L; Modena MG
    Maturitas; 2009 Mar; 62(3):243-7. PubMed ID: 19200669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk score.
    Balady GJ; Larson MG; Vasan RS; Leip EP; O'Donnell CJ; Levy D
    Circulation; 2004 Oct; 110(14):1920-5. PubMed ID: 15451778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Womens heart health series: a mini-symposium.
    McLarty A; Mann N; Lawson WE; Foster A
    Med Sci Monit; 2003 Jun; 9(6):RA103-10. PubMed ID: 12824960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in nonfatal coronary heart disease in the United States, 1980 through 1989.
    DeStefano F; Merritt RK; Anda RF; Casper ML; Eaker ED
    Arch Intern Med; 1993 Nov; 153(21):2489-94. PubMed ID: 8215754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease.
    Pearson TA
    Am J Cardiol; 2004 Nov; 94(9A):4F-8F. PubMed ID: 15519285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender significance of ST-segment deviation detected by ambulatory (Holter) monitoring.
    Nair CK; Khan IA; Mehta NJ; Ryschon KL; Nair RC
    Int J Cardiol; 2004 Jun; 95(2-3):153-7. PubMed ID: 15193813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should physicians measure high-sensitivity C-reactive protein levels to assess coronary heart disease risk?
    Alpert JS
    Am J Med; 2009 May; 122(5):405-6. PubMed ID: 19375543
    [No Abstract]   [Full Text] [Related]  

  • 17. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative.
    Blomkalns AL; Chen AY; Hochman JS; Peterson ED; Trynosky K; Diercks DB; Brogan GX; Boden WE; Roe MT; Ohman EM; Gibler WB; Newby LK;
    J Am Coll Cardiol; 2005 Mar; 45(6):832-7. PubMed ID: 15766815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presenting symptoms and diagnosis of coronary heart disease in women.
    Charney P
    J Cardiovasc Risk; 2002 Dec; 9(6):303-7. PubMed ID: 12478198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in prevention: preventing coronary heart disease; progress and prospects.
    Hayman LL; Hughes S
    J Cardiovasc Nurs; 2007; 22(5):349-50. PubMed ID: 17724414
    [No Abstract]   [Full Text] [Related]  

  • 20. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B; Mehta JL
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.